AF patients harboring CHIP mutations exhibited worse clinical features, including older age, longer AF duration, greater left atrial enlargement, higher E/E’ values indicative of diastolic dysfunction, and an increased prevalence of diabetes [40]. Here, STUB1 is linked to atrial fibrillation.